fda warning glp-1 november 2025 From a new Perspective by Amanda Banks, MD: On February 5, 2026, Hims & Hers, an online health and wellness platform, announced its intention to sell compounded oral semaglutide, a glucagon-like peptide-1 ( Pharmacovigilance Assessment of Compounded GLP-1
Description
Mixing alcohol with GLP-1 medications like semaglutide requires careful consideration
Track GLP-1 injections, weight, menstrual cycles, symptoms, and meals in one private journal
Starting a GLP-1 receptor agonist (GLP-1a) like Mounjaro, Ozempic, or Victoza can lead to meaningful improvements in blood sugar, weight, and appetite control
GLP-1 (glucagon-like peptide-1) medications have emerged as a groundbreaking class of drugs, primarily used in the treatment of type 2 diabetes
And the math only works one way for the vendor
